Ogden Christopher

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ogden Christopher's trades of CytomX Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15
S Sale
20,899 -9.6%
395.28
US$4,413,055 		20,899 -9.6% 395.28 US$4,413,055
2026-03-19 2026-03-17
S Sale
95,846 -1.2%
393.79
US$289,581 		95,846 -1.2% 393.79 US$289,581
2025-06-17 2025-06-16
S Sale
58,617 -35.6%
133.69
US$3,630,077 		58,617 -35.6% 133.69 US$3,630,077
2025-06-17 2025-06-13
S Sale
1,641 -0.8%
2.95
US$4,841 		1,641 -0.8% 2.95 US$4,841
2025-03-20 2025-03-18
S Sale
8,551 -4.1%
0.60
US$5,122 		8,551 -4.1% 0.60 US$5,122
2024-08-22 2024-08-20
S Sale
1,984 -1.8%
1.23
US$2,439 		1,984 -1.8% 1.23 US$2,439
2024-03-21 2024-03-19
S Sale
2,971 -3.4%
2.09
US$6,196 		2,971 -3.4% 2.09 US$6,196
2023-12-22 2023-12-20
S Sale
1,990 -3.9%
1.38
US$2,747 		1,990 -3.9% 1.38 US$2,747
2023-03-20 2023-03-16
S Sale
516 -1.3%
1.98
US$1,021 		516 -1.3% 1.98 US$1,021